Finally, exosomal L1CAM is produced by patient-derived primary GBM cells [40,41] and can be recovered from blood and ascites from ovarian cancer patients [42] and may promote as platform L1CAM cleavage or systemic delivery vehicle of membrane-bound L1CAM forms [43]. This evidence concerns the gene L1CAM and glioblastoma.